MORRISVILLE, N.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that CEO Alistair Macdonald has ...
Narrow-moat Syneos SYNH announced it will be acquired by a consortium of three private investment firms (Elliott Investment Management, Patient Square Capital, and Veritas Capital) for $43 per share ...
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health (SYNH) ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a ...
Good morning, ladies and gentlemen. Welcome to the Syneos Health Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback